A major challenge facing clinicians is to identify patients suspected of colorectal cancer in primary care. Recently, the National Institute of Health and Care Excellence (NICE) issued a revised NG12 Suspected Cancer: Recognition and Referral guideline, which now includes the use of faecal occult blood (FOB) testing in the patient diagnostic pathway.
The quantitative faecal immunochemical tests (FIT) is approximately 100 times more sensitive than traditional guaiac tests, detecting more early-stage cancers and advanced adenomas (pictured). The use of quantitative FIT within the NG12 detection and referral pathway will help to define those patients in need of an urgent referral.
OC Sensor is the leading quantitative FIT product, used worldwide in over 42 countries. Manufactured by Eiken Chemical since 1989, OC Sensor is the primary choice both for national bowel cancer screening programmes and routine laboratories. Building on over 20 years of experience, the OC Sensor platform features a unique sample collection device, compatible with a choice of dedicated analysers, ensuring the optimum solution for your laboratory.
